Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: a year ago

Possible Interaction: Vitamin D and Etidronate

supplement:

Vitamin D

Research Papers that Mention the Interaction

3) EHDP , at a dose of 2.5 mg/kg/day, inhibited the vitamin D induced hypercalcemia. (
Atherosclerosis  •  1975  |  View Paper
When disodium ethane-1-hydroxy-1,1-diphosphonate EHDP ) was administered (50 mg/kg b.wt) from 2 days before until 2 days after vitamin D3 treatment, cyst calcification was inhibited.
Experientia  •  2005  |  View Paper
We conclude that the combined treatment with etidronate and alfacalcidol additively increases the mass of bone with normal quality, resulting in bone strengthening in ovx rats.
Bone  •  2000  |  View Paper
To examine whether either of the two known active vitamin D metabolites 1,25(OH)2D3 or 24,25(OH)2D3 could reverse the mineralization defect induced by 1‐hydroxyethylidene‐1,1‐bis phosphonate (EHDP), a model of EHDP‐induced rickets was used.
The Anatomical record  •  1988  |  View Paper
This dose of EHDP enhances the intestinal accumulation of a vitamin D3 metabolite with the chromatographic characteristics of 1,25-dihydroxycholecalciferol.
Clinical science and molecular medicine  •  1975  |  View Paper
Abstract The administration of disodium-ethane-1-hydroxy-1,1-diphosphonate (20 mg/kg body weight subcutaneously) to chicks given adequate amounts of vitamin D 3 causes a hypercalcemia, inhibits bone mineralization, and inhibits intestinal calcium transport.
In rachitic chicks the disodium-ethane-1-hydroxy-1,1-diphosphonate treatment markedly reduces the 25-hydroxyvitamin D 3 -1-hydroxylase activity of kidney, but does not increase the 25-hydroxyvitamin D 3 -24-hydroxylase.
Archives of biochemistry and biophysics  •  1974  |  View Paper
Medical cost of concurrent therapy alphacalcidol and etidronate ) for osteoporosis was compared with those of no treatment and single therapies (alphacalcidol or etidronate) .
Clinical calcium  •  2002  |  View Paper